Full Text
PCN6 PRESERVED ANTITUMOR ACTIVITY AND REDUCED CARDIOTOXICITY OF FIRST-LINE PEGYLATED LIPOSOMAL DOXORUBICIN COMPARED WITH CONVENTIONAL DOXORUBICIN IN PATIENTS WITH METASTATIC BREAST CANCER

Abstract

Authors

K Mann C Rana A Wadhwa

Back to Volume 13, Issue 7
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×